Business Wire

MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.

SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the ...
Mena FN

MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X Technology'

ALISO VIEJO, Calif., Feb. 22, 2022 /PRNewswire/ -- MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow ...
PharmiWeb

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms

ALISO VIEJO, Calif., Jan. 9, 2020 /PRNewswire/ -- MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® ...
mp.pl

Initial experience with implantation of novel dual layer flow-diverter device FRED.

Flow-diverting stents can help treat complex and wide-necked cerebral aneurysms. The aim of the study was to evaluate initial experiences related to the safety and effectiveness of eight aneurysms ...
BioWorld

Microvention scores FDA nod for new aneurysm flow diverter

The U.S. has granted final approval to Microvention Inc., a subsidiary of Terumo Corp. based in Aliso Viejo, Calif., for its Flow Redirection Endoluminal Device (FRED) for the treatment of brain ...